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ABSTRACT
INTRODUCTION: The European Society of Cardiology classifies arterial pressure bellow 140/90 mmHg as 
optimal(below 120/80 mmHg), normal (120-129 mmHg for systolic and/or 80-84 mmHg for diastolic)  and 
high normal (130-139 mmHg for systolic and/or 85-89 mmHg for diastolic). The argument is concerned with 
different cardiovascular risk. The possibility of arterial hypertension (AH) to appear is higher in individ-
uals with high normal arterial pressure (HNAP). Such individuals could be treated with non-drug therapy 
as the idea is the appearance of AH to be delayed and the cardiovascular risk to be reduced. The aim of the 
study was the risk and hemodynamic profile of the students of medicine with HNAP to be examined. 
MATERIAL AND METHODS: The object of the investigation is focused on students of medicine with HNAP. 
The two followed-up groups – with HNAP and with optimal arterial blood pressure (OBP) assumed this pat-
tern on the base of inquiry and screening among 116 students (60 men and 56 women). Inquiry and anthro-
pometric methods, arterial pressure monitoring and impedance cardiography were carried up. 
RESULTS: The dominance of some factors, predisposing hypertension appearance as overweight, increased 
salt consumption, family history was registered in HNAP group. Hemodynamic evaluation manifested hy-
perkinetic type of circulation. 
CONCLUSION: Medical students’ risk and hemodynamic profile within HNAP group is close to that of the 
hypertensive individuals. That makes them a special risk group and there is a necessity of non-drug therapy 
means application in order for AH expression to be delayed.
Keywords: high normal AP, risk factors, impedance cardiography
INTRODUCTION
The arterial blood pressure (AP) is an integral 
index reflecting the functional state of the cardiovas-
cular system. Instead of it being a dynamic param-
eter with short- term and circadian deviations, it is 
maintained in definite referent values. The argument 
of the European Society of Cardiology (ESC) to de-
fine AP values under 140/90 mmHg in three catego-
10 Scripta Scientifica Medica, vol. 47, No 3, 2015, pp. 9-15 Copyright © Medical University of Varna
Risk profile and hemodynamic characteristics in young subjects with high normal arterial blood pressure
ries - optimal (under 120/80 mmHg), normal (120-
129 mmHg for systolic and/or 80-84 mmHg for dia-
stolic) and high normal (130-139 mmHg for systolic 
and/or 85-89 mmHg for diastolic) is connected to the 
different cardiovascular risks (1,2). The risk of arte-
rial hypertension (AH) to develop is higher in indi-
viduals with high normal AP (HNAP) (3,4,5,6,7,8).
 The individuals with HNAP are of interest be-
cause of the possibility of them to be treated by a 
non-drug therapy and thus delaying the AH appear-
ance and reducing the cardiovascular risk. Students 
of medicine are a special group, taking into consider-
ation their non-dynamics and proclivity for obesity, 
predisposing thus to AH.
The objective of the study is for the risky profile 
and some haemodynamic indices in the students of 
medicine to be followed.  
MATERIAL AND METHODS 
Screening of AP, measured by Мicrolife, Swit-
zerland device, was carried out among 116 students 
of medicine at the age of 23±1.3 years (60 men and 
56 women). Two groups were formed: with HNAP 
(n=23: 12 men and 11 women; 19,8%) and controls 
with optimal AP (OAP, n=28: 14 men and 14 wom-
en;  24,1%). 
Inquiry method: Family history, reduced physi-
cal activity, dietary habits leading to the appearance 
of AH and smoking as a separate risk factor for car-
diovascular diseases were registered.
Anthropometric examination, carried out by the 
ТАNITA BC-420 device. Body Mass Index (BMI)  - 
standard index for obesity assessment was a follow-
up. It is calculated as the body mass in kilograms is 
divided by the height in square meters, BMI=kg/m² 
(9, 10, 11).  The percentages of fat and water were cal-
culated too.
Monitoring of AP and heart rate (HR) by CNAP® 
”HD” (Biopac Instruments, USA). The systolic, dia-
stolic, mean AP and heart rate were followed within 
15 minutes after rest at night and 15 minutes at rest. 
The device consists of two cuffs - single and double. 
The single, i.e. standard one is placed on the arm, 
while the double one - on the hand’s fingers. CNAP® 
”HD” (Biopac Instruments, USA) works using the 
method of „vessel  emptying”  based on the Penaz’ 
principle (12,13,14). The pressure outside, carried by 
the finger cuffs could be changed thus maintaining 
constant blood volume within the fingers (the ves-
sel is clamped by a constant diameter).  The fingers’ 
blood volume is measured by an infrared sensor. The 
change of the vasomotor tone to each heart beat is 
corrected by a rapid analysis of the pulse wave, giving 
precise AP measurement of up to ±5 mmHg (6 kPa). 
Impedance cardiography (ICG), carried out by 
NICO100C (Biopac Instruments, USA). ICG is based 
on electrical voltage changes registered in the tho-
racic region (due to changes in the volume of eject-
ed blood within the systole) when an alternating cur-
rent with fixed frequency and amplitude is conduct-
ed (15, 16,17,18,19,20 ,21,22). Seventeen hemodynam-
ic indices are followed up by ICG and are reflected in 
details in table 5.
The statistical processing was carried out by 
SPSS 16 package - descriptive analysis and paired 
t-test.
RESULTS
The inquiry data (Table 1) show AH risk fac-
tors dominance in the HNAP group. The percentage 
of smoking in this group is 61.5%, while in the OAP 
group it is 38.5%. Almost doubled is the percentage 
of increased consumption of salt - 79% in HNAP in-





Tobacco smoking - 10 cigars mean per day 61.5% 38.5% р<0.05
Family history for arterial hypertension 17 % 14 % NS
Increased consumption of salt 79 % 43 % р<0.05
Reduced physical activity 71% 49% р<0.05
Table 1. Inquiry data in HNAP and OAP groups
Scripta Scientifica Medica, vol. 47, No 3, 2015, pp. 9-15  
Copyright © Medical University of Varna
  11
Julia Nikolova, Mariana Bacelova, Petar Hrischev et al.
The physical activity is almost twice as low in the stu-
dents with HNAP - 71% to 49% in OAP individuals. 
The family history for AH is of a higher percentage 
(17%), compared to the controls (14%).
The results from the anthropometric examina-
tion show that there is no significant difference be-
tween both groups regarding IBM and the percent-
age of body fats and water (Table 2).
The AP monitoring data reflect into details the 
systolic, diastolic and pulse AP values and HR values 
in both groups (Table 3). 
The monitoring indices mean values of the blood 
flow, peripheral vascular resistance and contractili-
ty thoracic flow content registered by ICG are repre-
sented on Table 4. Significantly higher (91.41±10.64) 
and shorter (0.26±0.03) are the heart rate and the me-
chanic systole duration in HNAP students in com-
parison to OAP, 70.53±10.91 and 0.29±0.02, respective-
ly. Velocity indices and vascular resistance show ten-
dency to be increased and the stroke volume to be de-
creased in HNAP individuals. 
DISCUSSION
The AP values under 140/90 mmHg are not a 
homogenic category. It is often divided by ESC into 
tree sub categories - optimal, normal and high nor-
mal (1,2). The students of medicine are an object of 


































Table 2. Anthropometric indices, measured by ТАNITA BC-420 devise in HNAP and OAP groups










S P (mmHg) 132.84±4.7 115.76±3.7 < 0.01*
D P (mmHg) 86.44±2.5 72.80±6.24 < 0.01*
H R (imp/min) 93.7± 16.4 70.7± 11 < 0.01*
P P (mmHg) 46.4± 2.2 42.96± 4.35 < 0.01*
Table 3. Arterial pressure (AP) and heart rate (HR) values in HNAP and OAP groups
SP – systolic pressure, DP- diastolic pressure, PP - pulse pressure, HR - heart rate, NHAP – high normal arterial pressure 
group; OAP – optimal arterial pressure group
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duced physical activity they undergo. The percentage 
of HNAP individuals is comparatively high (19.8%). 
As reasons there could be pointed predisposing fac-
tors such as increased consumption of salt, over-
weight, reduced physical activity. Higher percentage 
of family history for AH is present in this group too. 
It seems that the risk profile in hypertensives as in 
HNAP individuals is one and the same. In regard to 
this, the risk profile correction in HNAP objects will 
prevent the AH appearance (3,4,7,8,23,24,25,26,27,2
8,29). 
As far as the hemodynamic assessment is con-
cerned, the deviations in the HNAP group are simi-
lar to that seen in the first stage of AH - hyperkinetic 
type of circulation. Increased HR and shortened du-
ration of left ventricular ejection are registered too. 
This implies that the increased sympathetic tone, be-
ing a basis for the hyperkinetic model, is present in 
the HNAP students. Sympathetic tone dominance 
coupled with family pre-disposition is the leading 
factor in AH pathogenesis (29,30,31).
CONCLUSION 
The risk factors for HNAP are the same as those 
for AP. The hemodynamic profile of HNAP students 
of medicine indicates increased cardiac frequency 
and shortened duration for the left ventricular 
ejection and could be connected to increased 
sympathetic nerve activity.  
As far as the HNAP individuals’ therapeutic 
plan is concerned, the recommendation is directed 
to risk profile correction - reduction of body weight, 
consumption of salt, no smoking. The increased 
physical activity could regulate the autonomic nerve 
system disorder and reduce the sympathetic tone 
activity.   The early risk factors correction in students 
of medicine will delay the appearance of AH and 








Heart rate, HR (imp/s) 70.53±10.91 91.41±10.64 <0.01*
Thoracic fluid content, TFC (1/Ω) 0.033±0.01 0.033±0.01 >0.05
Velocity index, VI (1/s) 0.05±0.04 0.06±0.03 >0.05
Pre-ejection period, PEP(s) 0.13±0.02 0.12±0.01 >0.05
Left ventricular ejection time, LVET(s) 0.29±0.02 0.26±0.03 <0.05*
Stroke volume, SV(mL/beat) 104.75±56 79.08±24.81 >0.05
Stroke index, SI (mL/beat)/m2 54±33.9 42±13.61 >0.05
SV / SI 1.99±0.19 1.88±0.09 >0.05
Cardiac output, CO(L/min) 6.9±2.48 7.1±3.18 >0.05
Cardiac index, CI (L/min)/m2 3.5±1.57 3.8±1.79 >0.05
CO /CI 1.99±0.18 1.9±0.14 >0.05
Systemic vascular resistance, SVR (dynes/s/cm-5) 1017.87±283.29 1194±386.29 >0.05
Systemic vascular resistance index, SVRI (dynes.s. cm2. cm-5) 2032.5±578.69 2265.6±675.96 >0.05
Acceleration index, ACI(1/s2) 0.97±0.64 0.9±0.54 >0.05
Left cardiac work, LCW(kg.m) 6.98 ±2.50 7.15±3.20 >0.05
Left cardiac work index, LCWI (gm.m/m2) 3.57±1.57 3.78±1.80 >0.05
Systiolic time ratio, STR 0.43±0.05 0.60±0.36 >0.05
Table 4. Hemodynamic indices, registered by ICG in HNAP and OAP groups
HNAP – high normal arterial pressure group; OAP – optimal arterial pressure group.
The Stroke volume is calculated by Sramek-Bernstein formule (22)
Scripta Scientifica Medica, vol. 47, No 3, 2015, pp. 9-15  
Copyright © Medical University of Varna
  13
Julia Nikolova, Mariana Bacelova, Petar Hrischev et al.
REFERENCES
1. Kaplan, N. Kaplan’s Clinical Hyperten-
sion - ninth edition, Philadelphia, Lippincott, 
Williams&Wilkins, 2006, 11-12.
2. Reappraisal of European guidelines of 
hypertension management. Journal of Hypertens. 
2009; 27(11):2121-2158.
3. Gupta AK, McGlone M, Greenway FL et al. 
Prehypertension in disease-free adults: a marker for 
an adverse cardiometabolic risk profile. Hypertens 
Res. 2010; 33: 905-910
4. Lee M, Saver J, Chang B et al. Presence of baseline 
prehypertension and risk of incident stroke - a 
meta-analysis. Neurology. 2011; 77: 1330-1.
5. Conroy RM, Pyörälä K, Fitzgerald AP et al. 
Estimation of ten-year risk of fatal cardiovascular 
disease in Europe: the SCORE project. European 
Heart Journal. 2003; 24: 987-1003.
6. Lifon et al. Molecular mechanism of human hyper-
tension. Cell.  2001; vol 104, issue 4, 545-556.
7. FJ, Mac Gregor GA. A comprehensive review 
on salt and health and current experience of 
worldwide salt reduction programmes. J Hum 
Hypertens. 2009 ; 23(6):363-84.
8. Dickinson HO, Mason JM, Nikolson DJ, Compbell 
F, BeyerFR, Cook JJ, WilliamsB, Ford GA. Lifestyle 
interventions to reduce raised blood pressure: a 
systematic review of randomized controlled trials. 
Journal Hypertension. 2006; 2015-2033.
9. Gray DS, Fujioka K. Use of relative weight and 
Body Mass Index for the determination of 
adiposity. J Clin Epidemiol.1991;  44 (6): 545–50. 
10. Berrington de Gonzalez A, Hartge P, Cerhan JR, 
Flint AJ, Hannan L, MacInnis RJ et al. Body-Mass 
Index and Mortality among 1.46 Million White 
Adults. N. Engl. J. Med. 2010; 363 (23): 2211–9.  
11. Koleva D, Mitkov M,  Orbetsova M. Screening of 
obesity as a main risk factor for the development 
of metabolic syndrome.MedInfo.2012;4,7-9. (in 
Bulgarian) 
12. Dueck R, Jameson LC.  Reliability of hypotension 
detection with noninvasive radial artery beat-to-
beat versus upper arm cuff BP monitoring. Anesth 
Analg. 2006; 102 Suppl:S10.
13. Fortin, J, Marte, W, Grüllenberger, R, Hacker, 
A, Habenbacher, W, Heller, A et al. Continuous 
non-invasive blood pressure monitoring using 
concentrically interlocking control loops. 
Computers in biology and medicine. 2006; 36(9), 
941–57.
14. Cybulsky G. Ambulatory Impedance Cardiogra-
phy: The System and their Applications. 2011.
15. Sanidas EA, Grammatikopoulos K, Anastasiadis G, 
Papadopoulos D, Daskalaki M, Votteas V. Thoracic 
fluid content and impedance cardiography: a 
INDEX REFERENT VALUES
Heart rate, HR (imp/s) 58-86
Thoracic fluid content, TFC (1/Ω) 0.021- 0.050
Velocity index, VI(1/s) 0.033 - 0.065
Pre-ejection period, PEP(s) 0.05 - 0.12
Left ventricular ejection time, LVET(s) 0.25 - 0.35
Stroke Volume, SV (mL/beat) 60 - 250
Stroke Index, SI (ml/beat)/m2 35 - 65
Cardiac output CO(L/min) 4 - 8
Cardiac index (CI) (L/min)/m2 2.5 - 4.7
Systemic vascular resistance,  SVR (dynes/s/cm-5) 742 - 1378
Systemic vascular resistance index, SVRI (dynes.s.cm2. cm-5) 1337 - 2483
Acceleration index, ACI (1/s2) 0.7 – 1.7
Left cardiac work, LCW(kg.m) 3 – 5.5
Systiolic time ratio, STR 0.3 - 0.5
Table 5. Referent values and nomenclature of ICG indices by literally data
14 Scripta Scientifica Medica, vol. 47, No 3, 2015, pp. 9-15 Copyright © Medical University of Varna
Risk profile and hemodynamic characteristics in young subjects with high normal arterial blood pressure
novel and promising noninvasive method for 
assessing the hemodynamic effects of diuretics in 
hypertensive patients. 2009 Nov-Dec;50(6):465
16. Stevanović P, Šćepanović R , Radovanović D, 
Bajec D , Perunović R, Stojanović D, Stevanović 
D. Thoracic electrical bioimpedance theory and 
clinical possibilities in perioperative medicine . 
Signa Vitae 2008; 3 Suppl 1: S 22 - 27
17. Van De Water JM, Miller TW, Vogel RL, Mount 
BE, Dalton ML. Impedance cardiography: the next 
vital sign technology? Chest. 2003;123:2028-33.
18. Shoemaker WC, Wo CC, Bishop MH, 
Thangathurai D, Patil RS. Noninvasive 
hemodynamic monitoring of critical patients in 
the emergency department. Acad Emerg Med 
1996;3:675-81.
19. Humeau A, Steenbergen W, Nilsson H, Strömberg 
T, (2007) Laser Doppler perfusion monitoring 
and imaging: novel approaches. Med. Biol. Eng. 
Comput. 2007;45:421-435.
20. Iliev I, Tabakov S. Multichannel wideband 
measuring of bio-impedance with logarithmic 





21. Petrov G, Tsvetkov P, Iliev P. Non-invasive medical 
measuring devices. Metrology and metrological 
provision. Sozopol, 2006. (in Bulgarian)
22. Biopac MP hardware and software manuals.
23. Nikolov F.P. , Nikolov P. ,Nikolova J. Prevalence 
and Risk Profile of Prehypertension in South 
Bulgaria. Conference on PreHypertension & 
Cardio Metabolic Syndrome ;February 24-27, 2011, 
Vienna, Austria, PO-51.
24.  Vasan RS, Larson MG, Leip EP et al. Impact 
of high-normal blood pressure on the risk 
of cardiovascular disease. N EnglJ Med. 
2001;345:1291-7.
25. Wang Y, Wang QJ. The prevalence of prehyperten-
sion and hypertension among US adults according 
to the new National Joint Committee Guidelines. 
Arch. Int. Med. 2004; 164 (19):2126-34.
26.  Greenlund KJ, Croft JB, Mensah GA . Prevalence 
of heart disease and stroke risk factors in persons 
with pre hypertension in the United States. Arch. 
Int. Med .2004;164(19):2113-8.
27. Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse 
JM. Influence of weight reduction on blood 
pressure: a meta-analysis of randomized controlled 
trials. Hypertension. 2003; 42:878–884 MA. 
28.  He FJ, MacGregor GA. How far should salt intake 
be reduced. Hypertension. 2003; 42:1093–1099 RV.
29. Narkiewicz K, Phillips BG, Kato M et al. A gen-
der selective interaction between aging, blood pres-
sure and sympathetic nerve activity. Hypertension. 
2005; 45;522-52.
30. Cornelissen VA, Fagard RH. Effects of endurance 
training on blood hypertensive patients. 
Circulation. 2005; 111:1012–1018.
31. Julius S. et al.  Sympathetic overactivity in hyper-
tension Am J Hypertens. 1996; 113-120.
